Paul A. Thomas

Butterfield St
Herston, QLD 4029, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

68Ga-FAPI PET/CT Prevents Futile Surgery and Demonstrates Tumor Biology in Patients with Pancreatic Ductal Adenocarcinoma.

68Ga-FAPI PET/CT Prevents Futile Surgery and Demonstrates Tumor Biology in Patients with Pancreatic Ductal Adenocarcinoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 07, 2025

[18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial.

[18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial.

Journal: BMJ open

Published: August 04, 2023

Correction to: Prospective intra‑individual blinded comparison of [18F]PSMA‑1007 and [68 Ga]Ga‑PSMA‑11 PET/CT imaging in patients with confirmed prostate cancer.

Correction to: Prospective intra‑individual blinded comparison of [18F]PSMA‑1007 and [68 Ga]Ga‑PSMA‑11 PET/CT imaging in patients with confirmed prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 03, 2021

Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging.

Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging.

Journal: EJNMMI research

Published: August 11, 2021

Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer.

Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer.

Journal: Contrast media & molecular imaging

Published: July 02, 2021

Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic Review.

Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic Review.

Journal: Advances in urology

Published: June 09, 2021

Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer.

Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 22, 2021

Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation.

Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 13, 2021

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.

Journal: Theranostics

Published: January 02, 2020

PET Imaging Quantifying 68Ga-PSMA-11 Uptake in Metastatic Colorectal Cancer.

PET Imaging Quantifying 68Ga-PSMA-11 Uptake in Metastatic Colorectal Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 20, 2019

Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma.

Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma.

Journal: Clinical nuclear medicine

Published: October 18, 2016

Would you bet on PET? Evaluation of the significance of positive PET scan results post-microwave ablation for non-small cell lung cancer.

Would you bet on PET? Evaluation of the significance of positive PET scan results post-microwave ablation for non-small cell lung cancer.

Journal: Journal of medical imaging and radiation oncology

Published: December 10, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026